12 Partners (4 research institutes, 3 SMEs and 5 cancer clinics) from 6 different European and associated countries.

Azienda Ospedaliero Universitaria di Parma

AOP is coordinating the project and leads the clinical and scientific research for prospective studies.

More info

Universidad Politecnica de Madrid

UPM is the Technical Coordinator and leads the semantic framework and the overall BD2Decide design.

More info

Stichting VU University Medical Center

VUMC is responsible for the design of the clinical study and the prediction modelling.

More info

Heinrich-Heine-Universität Düsseldorf

UDUS contributes to the clinical studies with patients' data for validation of the project research.

More info

Fondazione IRCCS Istituto Nazionale dei Tumori

INT leads the clinical research in genomics, the genomics data collection and data analysis.

More info

Fraunhofer IGD Visual Computing

Fraunhofer offers solutions for tumor segmentation and image features extraction.

More info

Athens Technology Center S.A.

ATC leads the patients' data visualization and virtual representation tools.

More info

All in Image Ltd

All-in-Image leads the Big Data Infrastructure and the integration of population and other data for analysis.

More info

MAASTRICHT RADIATION ONCOLOGY MAASTRO

MAASTRO leads the CT scan radiomics task and participates in the clinical study.

More info

Politecnico di Milano

POLIMI leads the MRI scan radiomics task and the identification of radiomics signatures from MRI and DWI-MRI scans.

More info

MultiMed Engineers Srls

MME coordinates the exploitation and communication strategy and the actions for maximizing project impact.

More info

Università degli Studi di Parma

Unipr contributes to the clinical study setup and execution and the validation of the project results.

More info